Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2019-01-30

Clinical Trial Update: Spinal Cord Stimulation for Diabetic Polyneuropathy [NA]

View source ↗

Summary

Abbott Medical Devices' spinal cord stimulation trial for diabetic polyneuropathy has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Spinal Cord Stimulation system

Snippet

Sponsor: Abbott Medical Devices | Conditions: Diabetic Polyneuropathy | NA | Status: WITHDRAWN